New applications include ³Ô¹Ï±¬ÁÏ LIMS Basics and PromoMats Basics to drive speed and growth<\/i><\/p>\n
\nBARCELONA, Spain \u2014 4 Nov. 2025 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that more than 100 biotechs have selected ³Ô¹Ï±¬ÁÏ Basics<\/a> to advance operations across clinical, regulatory, and quality. A growing number of biotechs in the U.S. and Europe are establishing a foundation for growth with a simple and standard industry-leading solution that can scale as business needs evolve.\n<\/p>\n \nWith ³Ô¹Ï±¬ÁÏ Basics, biotechs leverage best-of-breed industry applications that are pre-configured and pre-validated for fast deployment. ³Ô¹Ï±¬ÁÏ Basics is built on the Vault Platform, enabling biotechs to move to a full Vault solution with no migration required. This provides companies with the technology and support for efficient processes across key business areas now and for the long term.\n<\/p>\n \n\u201cMore than 100 biotech leaders across 60 companies came together at ³Ô¹Ï±¬ÁÏ R&D and Quality Summit in Boston to learn, connect, and shape the future of ³Ô¹Ï±¬ÁÏ Basics. We\u2019re proud of the impact ³Ô¹Ï±¬ÁÏ Basics is making on emerging biotechs and will continue to add innovative new applications that can be implemented quickly to support the development of new medicines,\u201d said Steve Harper, general manager of ³Ô¹Ï±¬ÁÏ Basics.\n<\/p>\n To meet critical quality control (QC) and commercial needs, ³Ô¹Ï±¬ÁÏ Basics is adding two new applications:<\/p>\n \n³Ô¹Ï±¬ÁÏ LIMS (laboratory information management) Basics and PromoMats Basics are planned for availability in early 2026. Built on the proven Vault Platform, ³Ô¹Ï±¬ÁÏ Basics applications help customers to scale their technology infrastructure as they grow. For more on ³Ô¹Ï±¬ÁÏ Basics, visit veevabasics.com<\/a>.\n<\/p>\n What biotechs are saying about ³Ô¹Ï±¬ÁÏ Basics:<\/strong><\/p>\n \n\u201cAs a fast-growing company, we understood the value of ³Ô¹Ï±¬ÁÏ Basics standardizing our processes based on industry best practice. Knowing we have an agile solution that works now, while providing easy access to the ³Ô¹Ï±¬ÁÏ Vault Platform as we grow, gives us peace of mind that we can meet future requirements,\u201d said Richard Tornai, senior director IT, R&D Clinical at Structure Therapeutics.\n<\/p>\n \n\u201cBuilding a foundation for our quality and regulatory operations was a priority and we needed a compliant, cost-effective solution for document and record management. We believe ³Ô¹Ï±¬ÁÏ Basics fits those needs and more by providing logical workflows, a templated library of SOPs and forms, and simple and effective training,\u201d said Bryan Ball, chief technical operations officer at Whitehawk Therapeutics.\n<\/p>\n \n\u201c³Ô¹Ï±¬ÁÏ Basics delivered a best-of-breed solution with the global support to upskill our staff quickly. ³Ô¹Ï±¬ÁÏ\u2019s commitment to delivering innovation for biotechs and its focus on customer success make it the ideal partner,\u201d said Bernhard Irlinger, head of quality at AiCuris.\n<\/p>\n About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong> ###<\/center><\/p>\n\n
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n